Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the HCAI Executive Updates topic

No spam. Unsubscribe anytime.

HCAI reports workforce, budget and drug‑supply updates including $90M for distressed hospitals

Healthcare Affordability Advisory Committee · July 27, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

HCAI staff briefed the advisory committee on behavioral health workforce funding (WET plan), published analyses of youth behavioral health outcomes, GLP‑1 and insulin access studies, and a new $90 million allocation to assist financially distressed hospitals.

HCAI leadership opened the meeting with department‑level updates on behavioral‑health workforce investments, drug‑supply efforts and budget allocations for the new fiscal year. Director Landsberg summarized recently completed deliverables and new funding lines intended to support access and stabilize providers.

"So there's a new $90,000,000 allocation," Director Landsberg said, describing budget authority for grants to hospitals in financial distress and a directed requirement to better understand underlying causes of hospital financial instability. Staff also reported that HCAI will stand up a unit to assess hospitals' strategic importance, provide planning assistance, and deliver technical support to distressed facilities.

On behavioral health, HCAI noted the required five‑year Workforce Education and Training (WET) plan under the Behavioral Health Services Act and highlighted Mathematica’s recent analysis of California’s $4.7 billion Children and Youth Behavioral Health Initiative, including rollout of new wellness coach roles placed in schools and community organizations. HCAI staff flagged data briefs from the Health Care Payments Database showing rapid GLP‑1 adoption from 2018 to 2023 (from roughly 20,000 to over 700,000 prescriptions) with estimated 2023 statewide GLP‑1 costs of about $822 million across Medi‑Cal and commercial plans.

Committee members asked staff to continue tracking GLP‑1 trends, distinguish patient subgroups and monitor inequities in geographic access to insulin and metformin. HCAI said it plans to publish a Primary Care Snapshot (fall 2026) summarizing 20 indicators across investment, workforce, access, quality and equity.

These executive updates were informational; advisory members urged staff to continue refining metrics and to engage on follow‑up analyses of drug utilization, workforce impacts and hospital stabilization plans.